 SAN DIEGO--BUSINESS WIRE--Arcturus Therapeutics Holdings Inc. the Company, NASDAQ: ARCT, a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be offered by the Company. The offering is subject t 